05/15/2025 4:44 PM | 4D Molecular Therapeutics (Subject) Venrock Healthcare Capital Partners III, L.P. (Filed by)
| Form SCHEDULE 13G/A | |
05/08/2025 3:33 PM | 4D Molecular Therapeutics (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
04/29/2025 3:10 PM | 4D Molecular Therapeutics (Filer)
| Form ARS | |
03/24/2025 11:15 PM | 4D Molecular Therapeutics (Filer)
| Form EFFECT | |
03/10/2025 6:56 PM | 4D Molecular Therapeutics (Issuer) Kamal Fariborz (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/10/2025 6:57 PM | 4D Molecular Therapeutics (Issuer) Mehra Uneek (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/10/2025 6:58 PM | 4D Molecular Therapeutics (Issuer) Kim Robert Young (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/10/2025 6:58 PM | 4D Molecular Therapeutics (Issuer) Kirn David (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/10/2025 7:00 PM | 4D Molecular Therapeutics (Issuer) Bizily Scott (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/28/2025 3:57 PM | 4D Molecular Therapeutics (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/28/2025 4:07 PM | 4D Molecular Therapeutics (Filer)
| Form POS AM | |
Get the Latest News and Ratings for FDMT and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for 4D Molecular Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
|
02/14/2025 5:30 PM | 4D Molecular Therapeutics (Subject) RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SCHEDULE 13G/A | |
02/14/2025 5:09 PM | 4D Molecular Therapeutics (Subject) Venrock Healthcare Capital Partners III, L.P. (Filed by)
| Form SCHEDULE 13G/A | |
02/14/2025 10:34 AM | 4D Molecular Therapeutics (Subject) JANUS HENDERSON GROUP PLC (Filed by)
| Form SCHEDULE 13G/A | |
02/14/2025 7:40 AM | 4D Molecular Therapeutics (Subject) Deep Track Capital, LP (Filed by)
| Form SCHEDULE 13G/A | |
02/10/2025 4:28 PM | 4D Molecular Therapeutics (Subject) GOLDMAN SACHS GROUP INC (Filed by) GOLDMAN SACHS GROUP INC (Filed by)
| Form SCHEDULE 13G/A | |
02/10/2025 7:37 AM | 4D Molecular Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/10/2025 7:36 AM | 4D Molecular Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/11/2024 3:15 PM | 4D Molecular Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/15/2024 4:05 PM | 4D Molecular Therapeutics (Subject) RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13G/A | |
11/14/2024 4:46 PM | 4D Molecular Therapeutics (Subject) RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13G/A | |
11/14/2024 2:15 PM | 4D Molecular Therapeutics (Subject) JANUS HENDERSON GROUP PLC (Filed by)
| Form SC 13G/A | |
11/14/2024 8:13 AM | 4D Molecular Therapeutics (Subject) Deep Track Capital, LP (Filed by)
| Form SC 13G/A | |
11/13/2024 3:33 PM | 4D Molecular Therapeutics (Issuer) BIOTECHNOLOGY VALUE FUND II LP (Reporting) BIOTECHNOLOGY VALUE FUND L P (Reporting) Biotechnology Value Trading Fund OS LP (Reporting) BVF GP HOLDINGS LLC (Reporting) BVF I GP LLC (Reporting) BVF II GP LLC (Reporting) BVF INC/IL (Reporting) BVF PARTNERS L P/IL (Reporting) BVF Partners OS Ltd. (Reporting) LAMPERT MARK N (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/13/2024 3:17 PM | 4D Molecular Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/13/2024 3:08 PM | 4D Molecular Therapeutics (Subject) BIOTECHNOLOGY VALUE FUND L P (Filed by)
| Form SC 13G/A | |
11/12/2024 11:12 AM | 4D Molecular Therapeutics (Subject) VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
11/08/2024 1:17 PM | 4D Molecular Therapeutics (Subject) BlackRock, Inc. (Filed by)
| Form SC 13G/A | |
11/06/2024 5:07 PM | 4D Molecular Therapeutics (Subject) GOLDMAN SACHS GROUP INC (Filed by) GOLDMAN SACHS GROUP INC (Filed by)
| Form SC 13G | |
11/04/2024 9:55 AM | 4D Molecular Therapeutics (Subject) VANGUARD GROUP INC (Filed by)
| Form SC 13G | |
10/21/2024 3:11 PM | 4D Molecular Therapeutics (Subject) BlackRock, Inc. (Filed by)
| Form SC 13G/A | |
09/18/2024 4:46 PM | 4D Molecular Therapeutics (Issuer) Bizily Scott (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/18/2024 3:06 PM | 4D Molecular Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/23/2024 5:04 AM | 4D Molecular Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/18/2024 7:22 PM | 4D Molecular Therapeutics (Issuer) Bizily Scott (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/17/2024 5:04 AM | 4D Molecular Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/15/2024 5:13 PM | 4D Molecular Therapeutics (Issuer) Bizily Scott (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/12/2024 4:46 PM | 4D Molecular Therapeutics (Issuer) Kirn David (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/10/2024 4:17 PM | 4D Molecular Therapeutics (Subject) Kirn David (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/03/2024 4:11 PM | 4D Molecular Therapeutics (Issuer) Bizily Scott (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/01/2024 3:43 PM | 4D Molecular Therapeutics (Subject) Bizily Scott (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
Market Panic: Trump Just Dropped a Bomb on Your Stocks (Ad) tock Market Panic: Trump Just Dropped a Bomb on Your Stocks
The market is in freefall—and Trump's new tariffs just lit the fuse.
Millions of investors are blindsided as stocks plunge… but this is only Phase 1.
If you're still holding the wrong assets, you could lose 30% or more in the coming weeks. Don't wait for the next drop to wipe you out. Get the FREE Guide Before Markets Open Tomorrow |
06/26/2024 4:07 PM | 4D Molecular Therapeutics (Issuer) Kirn David (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/25/2024 3:44 PM | 4D Molecular Therapeutics (Subject) Kirn David (Reporting)
| Form 144/A | |
06/24/2024 4:39 PM | 4D Molecular Therapeutics (Subject) Kirn David (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/07/2024 4:04 PM | 4D Molecular Therapeutics (Filer)
| Form 424B5 | |
06/07/2024 4:07 PM | 4D Molecular Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/23/2024 7:45 PM | 4D Molecular Therapeutics (Issuer) Tomasello Shawn (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/23/2024 6:10 PM | 4D Molecular Therapeutics (Issuer) GRAY SUSANNAH (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/23/2024 6:11 PM | 4D Molecular Therapeutics (Issuer) MILLIGAN JOHN F (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/23/2024 6:12 PM | 4D Molecular Therapeutics (Issuer) Miller-Rich Nancy (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/23/2024 6:16 PM | 4D Molecular Therapeutics (Issuer) THEUER CHARLES (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/23/2024 6:17 PM | 4D Molecular Therapeutics (Issuer) Chacko Jacob (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |